Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

• Váldodahkkit: Arnon D. Cohen, MD, MPH, PhD (Dahkki), Ronald Vender, MD, FRCPC (Dahkki), Luigi Naldi, MD (Dahkki), Robert E. Kalb, MD (Dahkki), Tiago Torres, MD, PhD (Dahkki), Murlidhar Rajagopalan, MD (Dahkki), Joelle van der Walt, PhD (Dahkki), Lluís Puig, MD (Hon) (Dahkki), Helen S. Young, MB ChB, PhD, FRCP (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2020-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: As biosimilars have become available in various parts of the world, the International Psoriasis Council has reviewed aspects of their use. Objective: To provide consensus statements from the Biosimilar Working Group about the use of biosimilars in patients with psoriasis. Methods: A semi...